The impact of a comprehensive coronavirus disease 2019 (COVID-19) infection prevention bundle on non-COVID-19 hospital-acquired respiratory viral infection (HA-RVI) rates.

Jessica L SeidelmanLauren DiBiaseIbukunoluwa C KaluSarah S LewisEmily Sickbert-BennettDavid Jay WeberBecky A Smith

Published in: Infection control and hospital epidemiology (2022)

After implementing a coronavirus disease 2019 (COVID-19) infection prevention bundle, the incidence rate ratio (IRR) of non-severe acute respiratory coronavirus virus 2 (non-SARS-CoV-2) hospital-acquired respiratory viral infection (HA-RVI) was significantly lower than the IRR from the pre-COVID-19 period (IRR, 0.322; 95% CI, 0.266-0.393; P < .01). However, HA-RVIs incidence rates mirrored community RVI trends, suggesting that hospital interventions alone did not significantly affect HA-RVI incidence.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
healthcare
risk factors
acute care
adverse drug
mental health
respiratory tract
physical activity
emergency department
quality improvement